134 related articles for article (PubMed ID: 12776208)
1. Transcriptional analysis of targets in multiple sclerosis.
Steinman L; Zamvil S
Nat Rev Immunol; 2003 Jun; 3(6):483-92. PubMed ID: 12776208
[TBL] [Abstract][Full Text] [Related]
2. The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease.
Chabas D; Baranzini SE; Mitchell D; Bernard CC; Rittling SR; Denhardt DT; Sobel RA; Lock C; Karpuj M; Pedotti R; Heller R; Oksenberg JR; Steinman L
Science; 2001 Nov; 294(5547):1731-5. PubMed ID: 11721059
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional profiling of multiple sclerosis: towards improved diagnosis and treatment.
Lindberg RL; Kappos L
Expert Rev Mol Diagn; 2006 Nov; 6(6):843-55. PubMed ID: 17140371
[TBL] [Abstract][Full Text] [Related]
4. Lack of requirement of osteopontin for inflammation, bone erosion, and cartilage damage in the K/BxN model of autoantibody-mediated arthritis.
Jacobs JP; Pettit AR; Shinohara ML; Jansson M; Cantor H; Gravallese EM; Mathis D; Benoist C
Arthritis Rheum; 2004 Aug; 50(8):2685-94. PubMed ID: 15334485
[TBL] [Abstract][Full Text] [Related]
5. Multiplexing approaches for autoantibody profiling in multiple sclerosis.
Somers K; Govarts C; Stinissen P; Somers V
Autoimmun Rev; 2009 Jun; 8(7):573-9. PubMed ID: 19393211
[TBL] [Abstract][Full Text] [Related]
6. Neuromyelitis optica/Devic's disease: gene expression profiling of brain lesions.
Satoh J; Obayashi S; Misawa T; Tabunoki H; Yamamura T; Arima K; Konno H
Neuropathology; 2008 Dec; 28(6):561-76. PubMed ID: 18410276
[TBL] [Abstract][Full Text] [Related]
7. HIV-associated dementia, Alzheimer's disease, multiple sclerosis, and schizophrenia: gene expression review.
Minagar A; Shapshak P; Duran EM; Kablinger AS; Alexander JS; Kelley RE; Seth R; Kazic T
J Neurol Sci; 2004 Sep; 224(1-2):3-17. PubMed ID: 15450765
[TBL] [Abstract][Full Text] [Related]
8. Blood transcriptional signatures of multiple sclerosis: unique gene expression of disease activity.
Achiron A; Gurevich M; Friedman N; Kaminski N; Mandel M
Ann Neurol; 2004 Mar; 55(3):410-7. PubMed ID: 14991819
[TBL] [Abstract][Full Text] [Related]
9. Multiple sclerosis: a complicated picture of autoimmunity.
McFarland HF; Martin R
Nat Immunol; 2007 Sep; 8(9):913-9. PubMed ID: 17712344
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to disease.
Bomprezzi R; Ringnér M; Kim S; Bittner ML; Khan J; Chen Y; Elkahloun A; Yu A; Bielekova B; Meltzer PS; Martin R; McFarland HF; Trent JM
Hum Mol Genet; 2003 Sep; 12(17):2191-9. PubMed ID: 12915464
[TBL] [Abstract][Full Text] [Related]
11. Tagging mammalian transcription complexity.
Carninci P
Trends Genet; 2006 Sep; 22(9):501-10. PubMed ID: 16859803
[TBL] [Abstract][Full Text] [Related]
12. Genomics in multiple sclerosis--current state and future directions.
Comabella M; Martin R
J Neuroimmunol; 2007 Jul; 187(1-2):1-8. PubMed ID: 17400297
[TBL] [Abstract][Full Text] [Related]
13. Osteopontin gene and clinical severity of multiple sclerosis.
Hensiek AE; Roxburgh R; Meranian M; Seaman S; Yeo T; Compston DA; Sawcer SJ
J Neurol; 2003 Aug; 250(8):943-7. PubMed ID: 12928913
[TBL] [Abstract][Full Text] [Related]
14. Improved representation of gene markers on microarray by PCR-Select subtracted cDNA targets.
Yakubov E; Dinerman P; Kuperstein F; Saban S; Yavin E
Brain Res Mol Brain Res; 2005 Jun; 137(1-2):110-8. PubMed ID: 15950768
[TBL] [Abstract][Full Text] [Related]
15. Impact of haloperidol and risperidone on gene expression profile in the rat cortex.
Fehér LZ; Kálmán J; Puskás LG; Gyülvészi G; Kitajka K; Penke B; Palotás M; Samarova EI; Molnár J; Zvara A; Matin K; Bódi N; Hugyecz M; Pákáski M; Bjelik A; Juhász A; Bogáts G; Janka Z; Palotás A
Neurochem Int; 2005 Sep; 47(4):271-80. PubMed ID: 15941608
[TBL] [Abstract][Full Text] [Related]
16. Microarray RNA transcriptional profiling: part II. Analytical considerations and annotation.
Ahmed FE
Expert Rev Mol Diagn; 2006 Sep; 6(5):703-15. PubMed ID: 17009905
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profiling of cathepsin D, metallothioneins-1 and -2, osteopontin, and tenascin-C in a mouse spinal cord injury model by cDNA microarray analysis.
Hashimoto M; Koda M; Ino H; Yoshinaga K; Murata A; Yamazaki M; Kojima K; Chiba K; Mori C; Moriya H
Acta Neuropathol; 2005 Feb; 109(2):165-80. PubMed ID: 15592854
[TBL] [Abstract][Full Text] [Related]
18. NeurimmiRs: microRNAs in the neuroimmune interface.
Soreq H; Wolf Y
Trends Mol Med; 2011 Oct; 17(10):548-55. PubMed ID: 21813326
[TBL] [Abstract][Full Text] [Related]
19. No evidence of pancreatic autoimmunity among patients with multiple sclerosis.
Bilbao JR; Villoslada P; Martin-Pagola A; Castaño L
Ann N Y Acad Sci; 2004 Dec; 1037():133-7. PubMed ID: 15699507
[TBL] [Abstract][Full Text] [Related]
20. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity.
Wiendl H; Feger U; Mittelbronn M; Jack C; Schreiner B; Stadelmann C; Antel J; Brueck W; Meyermann R; Bar-Or A; Kieseier BC; Weller M
Brain; 2005 Nov; 128(Pt 11):2689-704. PubMed ID: 16123145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
